COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 805: Articles 8041-8050  | Next

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July - November 2021.
Starrfelt, J., Danielsen, A. S., Buanes, E. A., Juvet, L. K., Lyngstad, T. M., Roe, G. O. I., Veneti, L., Watle, S. V., Meijerink, H.
10.1101/2022.03.29.22273086 — Posted: 2022-03-30
Severe outcomes in unvaccinated COVID-19 cases <18 years during different variant waves in Norway
Whittaker, R., Greve-Isdahl, M., Boas, H., Suren, P., Buanes, E., Veneti, L.
10.1101/2022.03.29.22273093 — Posted: 2022-03-30
Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approaches
Hoque, M. N., Khan, M. A., Hossain, M. A., Hasan, M. I., Rahman, M. H., Soliman, M. E., Araf, Y., Zheng, C., Islam, T.
10.1101/2022.03.30.486356 — Posted: 2022-03-30
SARS-CoV-2 accessory protein ORF8 decreases antibody-dependent cellular cytotoxicity
Beaudoin-Bussieres, G., Arduini, A., Bourassa, C., Medjahed, H., Gendron-Lepage, G., Richard, J., Pan, Q., Wang, Z., Liang, C., Finzi, A.
10.1101/2022.03.30.486403 — Posted: 2022-03-30
ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies
Low, J. S., Jerak, J., Tortorici, M. A., McCallum, M., Pinto, D., Cassotta, A., Foglierini, M., Mele, F., Abdelnabi, R., Weynand, B., Noack, J., Montiel-Ruiz, M., Bianchi, S., Benigni, F., Sprugasci, N., Joshi, A., Bowen, J. E., Walls, A. C., Jarrossay, D., Morone, D., Paparoditis, P., Garzoni, C., Ferrari, P., Ceschi, A., Neyts, J., Purcell, L. A., Snell, G., Corti, D., Lanzavecchia, A., Veesler, D., Sallusto, F.
10.1101/2022.03.30.486377 — Posted: 2022-03-30
Impact of the Russian invasion of Ukraine onthe COVID-19 pandemic dynamics
Nesteruk, I.
10.1101/2022.03.26.22272979 — Posted: 2022-03-30
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses
Gummuluru, S., Jalloh, S., Olejnik, J., Berrigan, J., Nisa, A., Suder, E. L., Akiyama, H., Lei, M., Tyagi, S., Bushkin, Y., Muhlberger, E.
10.1101/2022.03.29.486190 — Posted: 2022-03-29
Repeated ethanol exposure and withdrawal alters ACE2 expression in discrete brain regions: Implications for SARS-CoV-2 infection
Balasubramanian, N., James, T. D., Pushpavathi, S. G., Marcinkiewcz, C. A.
10.1101/2022.03.29.486282 — Posted: 2022-03-29
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
Lima, N. S., Mukhamedova, M., Johnston, T. S., Wagner, D. A., Henry, A. R., Wang, L., Yang, E. S., Zhang, Y., Birungi, K., Black, W. P., O'Dell, S., Schmidt, S. D., Moon, D., Lorang, C. G., Zhao, B., Chen, M., Boswell, K., Roberts-Torres, J., Davis, R. L., Peyton, L., Narpala, S. R., O'Connell, S., Wang, J., Schrager, A., Talana, C. A., Leung, K., Shi, W., Khashab, R., Biber, A., Zilberman, T., Rhein, J., Vetter, S., Ahmed, A., Novik, L., Widge, A., Gordon, I., Guech, M., Teng, I.-T., Phung, E., Ruckwardt, T., Pegu, A., Misasi, J., Doria-Rose, N. A., Gaudinski, M., Koup, R. A., Kwong, P. D., McDermott, A. B., Amit, S., Schacker, T. W., Levy, I., Mascola, J. R., Sullivan, N. J., Schramm, C. A., Douek, D. C.
10.1101/2022.03.28.486152 — Posted: 2022-03-29
Subcellular mapping of the protein landscape of SARS-CoV-2 infected cells for target-centric drug repurposing
Kaimal, J. M., Tampere, M., Le, T. H., Axelsson, U., Xu, H., Axelsson, H., Backstrom, A., Marabita, F., Moussaud-Lamodiere, E., Njenda, D., Sepulveda, C. O., Ouyang, W., Seashore-Ludlow, B., Vernersson, C., Mirazimi, A., Lundberg, E., Ostling, P., Stadler, C.
10.1101/2022.03.29.482838 — Posted: 2022-03-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).